OMC
SLXNW

Oasis Management Company’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Oasis Management Company’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.2K Hold
11,111
– – ﹤0.01% 109
2025
Q4 		$21.3K Hold
11,111
– – ﹤0.01% 103
2025
Q3 		$37.8K Buy
+11,111
New +$390 ﹤0.01% 108

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 36.38% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

Oasis Management Company's SLXNW Position: Q1 2026 in Review

Oasis Management Company held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 11,111 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #109.

Oasis Management Company first reported a position in SLXNW in Q3 2025 and has held it in 3 quarters since. The position peaked at $37.8K in Q3 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Oasis Management Company held 11,111 shares of Silexion Therapeutics Warrant worth $14.2K as of Q1 2026.
  • Oasis Management Company left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
  • Silexion Therapeutics Warrant made up ﹤0.01% of Oasis Management Company's portfolio in Q1 2026, its #109 holding.
  • Oasis Management Company first reported a position in Silexion Therapeutics Warrant in Q3 2025 and has held it in 3 quarters since.
  • Oasis Management Company's Silexion Therapeutics Warrant position peaked at $37.8K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Oasis Management Company's 13F filing for Q1 2026, filed 15 May 2026.